| Ident. | Authors (with country if any) | Title |
|---|
| 001571 (2006) |
Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | Avian influenza virus infections in humans |
| 001735 (2003) |
Ioannis Stylianakis [Grèce] ; Antonios Kolocouris [Grèce] ; Nicolas Kolocouris [Grèce] ; George Fytas [Grèce] ; George B. Foscolos [Grèce] ; Elizaveta Padalko [Belgique] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique] | Spiro[pyrrolidine-2,2'-adamantanes]: Synthesis, anti-influenza virus activity and conformational properties |
| 001739 (2003) |
G. A. Marsh [Australie] ; J. M. Watson [Australie] ; W. E. White [Australie] ; G. A. Tannock [Australie] | An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets |
| 001793 (2002) |
I. V. Kiseleva ; A. I. Klimov | En Russe |
| 001984 (1999) |
Antonios Kolocouris [Grèce] ; Dimitrios Tataridis [Grèce] ; George Fytas [Grèce] ; Thomas Mavromoustakos [Grèce] ; George B. Foscolos [Grèce] ; Nicolas Kolocouris [Grèce] ; Erik De Clercq [Belgique] | Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling |
| 001997 (1999) |
Venkatram R. Atigadda [États-Unis] ; Wayne J. Brouillette [États-Unis] ; Franco Duarte [États-Unis] ; Yarlagadda S. Babu [États-Unis] ; Shanta Bantia [États-Unis] ; Pooran Chand [États-Unis] ; Naiming Chu [États-Unis] ; John A. Montgomery [États-Unis] ; David A. Walsh [États-Unis] ; Elise Sudbeck [États-Unis] ; James Finley [États-Unis] ; Gillian M. Air [États-Unis] ; Ming Luo [États-Unis] ; Graeme W. Laver [Australie] | Hydrophobic benzoic acids as inhibitors of influenza neuraminidase |
| 001A38 (1999) |
M. Kobayashi [États-Unis] ; S. M. Davis [États-Unis] ; T. Utsunomiya [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | Antiviral effect of gingyo-san, a traditional chinese herbal medicine, on influenza A2 virus infection in mice |
| 001A96 (1998) |
A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni] | Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2) |
| 001B04 (1998) |
C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis] | How to overcome resistance of influenza A viruses against adamantane derivatives |
| 001B20 (1998) |
S. Bantia [États-Unis] ; A. A. Ghate [États-Unis] ; S. L. Ananth [États-Unis] ; Y. Sudhakar Babu [États-Unis] ; G. M. Air [États-Unis] ; G. M. Walsh [États-Unis] | Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140 |
| 001B55 (1997) |
Brian R. Murphy [États-Unis] ; Eun Ju Park [États-Unis] ; Paul Gottlieb [États-Unis] ; Kanta Subbarao [États-Unis] | An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters |
| 001C09 (1996) |
Nicolas Kolocouris [Belgique] ; Antonios Kolocouris [Belgique] ; George B. Foscolos [Belgique] ; George Fytas [Belgique] ; Johan Neyts [Belgique] ; Elisabeth Padalko [Belgique] ; Jan Balzarini [Belgique] ; Robert Snoeck [Belgique] ; Graciela Andrei [Belgique] ; Erik De Clercq [Belgique] | Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2 |
| 001C90 (1996) |
K. G. Nicholson [Royaume-Uni] | Use of antivirals in influenza in the elderly : Prophylaxis and therapy |
| 001D33 (1995) |
G. A. Tannock [Australie] ; J. R. Romanova [Russie] ; J. A. Paul [Australie] | The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene |
| 001E15 (1994) |
M. A. Ball [États-Unis] ; T. Utsunomiya [États-Unis] ; K. Ikemoto [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice |
| 001E22 (1994) |
B. Schweiger [Allemagne] ; I. Lange [Allemagne] ; R. Heckler [Allemagne] ; H. Willers [Allemagne] ; E. Schreier [Allemagne] | Rapid detection of influenza A neuraminidase subtypes by cDNA amplification coupled to a simple DNA enzyme immunoassay |
| 001E47 (1994) |
M. Tamura [États-Unis] ; R. G. Webster ; F. A. Ennis [États-Unis] | Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses |
| 001E68 (1993) |
Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis] | Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge |
| 001F17 (1993) |
T. E. Medvedeva [Russie] ; V. K. Kudryavtseva ; G. N. Nevedomskaya ; I. V. Zhikhareva ; M. I. Gushchina ; F. N. Zolotarev ; G. M. Vodeiko ; K. V. Lisovskaya ; V. V. Iotov ; M. I. Khaider ; V. V. Yarosh ; A. I. Klimov ; G. I. Aleksandrova | Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/leningrad/134/47/57 (H2N2), a donor for attenuation of living influenza vaccines |
| 001F18 (1993) |
J. R. Sch Fer [États-Unis] ; Yoshihiro Kawaoka [États-Unis] ; W. J. Bean [États-Unis] ; J. Süss ; D. Senne ; R. G. Webster [États-Unis] | Origin of the pandemic 1957 H2 influenza A viruses and the persistence of its possible progenitors in the avian reservoir |
| 001F19 (1993) |
M. L. Herlocher [États-Unis] ; H. F. Maassab ; R. G. Webster [États-Unis] | Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus |
| 001F20 (1993) |
H. Nakao [Japon] ; K. Nakajima [Japon] ; S. Nakajima | Location on the evolutionary trees of the non-structural protein (NS) and neuraminidase (NA) genes of late human influenza A (H3N2) viruses : parental viruses of the NS and NA genes of Hong Kong influenza A (H3N2) viruses |
| 001F21 (1993) |
R. A. Black [États-Unis] ; P. A. Rota [États-Unis] ; N. Gorodkova ; H.-D. Klenk ; A. P. Kendal [États-Unis] | Antibody response to the M2 protein of influenza A virus expressed in insect cells |
| 001F22 (1993) |
Y. Okuno [Japon] ; Y. Isegawa ; F. Sasao ; S. Ueda | A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains |
| 001F37 (1992) |
Alexander I. Klimov [Russie] ; Nancy J. Cox [États-Unis] ; Wagner V. Yotov [Russie] ; Elisabet Rocha [États-Unis] ; Galina I. Alexandrova [Russie] ; Alan P. Kendal [États-Unis] | Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus |
| 001F88 (1992) |
E. Kanta Subbarao [États-Unis] ; M. Perkins ; J. J. Treanor ; B. R. Murphy | The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect |
| 002063 (1991) |
B. Panzing [Allemagne] ; K. B. Lisovskaya ; B. Herrman ; A. Klimov ; L. Döhner | Further studies on cold adapted variants of human influenza virus A/Krasnodar/101/59 (H2N2) with special reference to genetic stability of attenuation markers |
| 002128 (1990) |
I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. Couch | Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes |
| 002191 (1989) |
M. H. Pritchard ; J. Munro | Successful treatment of juvenile chronic arthritis with a specific antiviral agent |
| 002192 (1989) |
Yoshihiro Kawaoka [États-Unis] ; S. Krauss ; R. G. Webster | Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics |
| 002250 (1988) |
Nancy J. Cox [États-Unis] ; Fumio Kitame [Japon] ; Alan P. Kendal [États-Unis] ; Hunein F. Maassab [États-Unis] ; Clayton Naeve [États-Unis] | Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2) |
| 002270 (1988) |
R. B. Belshe ; M. Hall Smith ; C. B. Hall ; R. Betts ; A. J. Hay | Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection |
| 002271 (1988) |
M. H. Snyder ; R. F. Betts ; D. Deborde ; E. L. Tierney ; M. L. Clements ; D. Herrington ; S. D. Sears ; R. Dolin ; H. F. Maassab ; B. R. Murphy | Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines |
| 002272 (1988) |
A. Z. Plyusnin ; S. A. Rozhkova ; O. V. Nolandt ; E. A. Bryantseva ; F. S. Poskov | |
| 002326 (1987) |
G. A. Tannock [Australie] ; Judith A. Paul [Australie] | Homotypic and heterotypic immunity of influenza A viruses induced by recombinants of the cold-adapted master strain A/Ann Arbor/6/60-ca |
| 002334 (1987) |
E. E. Rozina ; O. E. Khudaverdyan ; Yu. Z. Ghendon | Clinical and morphologic studies on the guinea pig eye infected with human influenza virus strains of different virulence |
| 002352 (1986) |
Tadao Sonoguchi [Japon] ; Mitsuo Sakoh [Japon] ; Nobuharu Kunita [Japon] ; Kiyoaki Satsuta [Japon] ; Hideo Noriki [Japon] ; Hideo Fukumi [Japon] | Reinfection with Influenza A (H2N2, H3N2, and H1N1) Viruses in Soldiers and Students in Japan |
| 002406 (1986) |
J. R. Bennink ; J. W. Yewdell ; G. L. Smith ; B. Moss | Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes |
| 002420 (1985) |
D. B. Golubev [Russie] ; G. I. Karpukhin [Russie] ; S. S. Galitarov [Russie] ; G. M. Denisov [Russie] | Type A influenza (H2N2) viruses isolated in Leningrad in 1980 |
| 002426 (1985) |
Sukla Basak [États-Unis] ; Milan Tomana [États-Unis] ; Richard W. Compans [États-Unis] | Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase |
| 002473 (1985) |
SHU-FANG TIAN ; A. J. Buckler-White ; W. T. London ; L. J. Reck ; R. M. Chanock ; B. R. Murphy | Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract |
| 002496 (1984) |
W. Graeme Laver [République populaire de Chine] ; Robert G. Webster [République populaire de Chine] ; C. M. Chu [République populaire de Chine] | Summary of a Meeting on the Origin of Pandemic Influenza Viruses |
| 002523 (1984) |
A. Yamada [États-Unis] ; L. E. Brown [États-Unis] ; R. G. Webster [États-Unis] | Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: Influence of receptor specificity |
| 002530 (1984) |
R. G. Webster [États-Unis] ; L. E. Brown [États-Unis] ; W. G. Laver [États-Unis] | Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies |
| 002541 (1984) |
K. Nerome [Japon] ; Y. Yoshioka [Japon] ; C. A. Torres [Japon] ; A. Oya [Japon] ; P. Bachmann [Allemagne] ; K. Ottis [Allemagne] ; R. G. Webster [États-Unis] | Persistence of Q strain of H2N2 influenza virus in avian species: Antigenic, biological and genetic analysis of avian and human H2N2 viruses |
| 002552 (1984) |
R. B. Belshe ; L. P. Van Voris ; J. Bartram ; F. K. Crookshanks | Live attenuated influenza A virus vaccines in children: results of a field trial |
| 002553 (1984) |
D. A. Buonagurio ; M. Krystal ; P. Palese ; D. C. Deborde ; H. F. Maassab | Analysis of an influenza A virus mutant with a deletion in the NS segment |
| 002554 (1984) |
I. M. Ismajlova ; E. I. Isaeva | |
| 002627 (1983) |
F. I. Polezhaev ; G. N. Budilovskij ; L. M. Garmashova ; Yu. R. Romejko-Gurko ; A. Yu. Egorov ; N. V. Topuriya ; T. A. Koval ; G. I. Aleksandrova | |
